Published in Neuropsychiatr Dis Treat on June 01, 2006
The developing utility of zebrafish models for cognitive enhancers research. Curr Neuropharmacol (2012) 0.84
Neuropsychiatry: where are we and where do we go from here? Mens Sana Monogr (2013) 0.75
Editor's choice: the best of 2011-2012. Neuropsychiatr Dis Treat (2013) 0.75
A rating scale for depression. J Neurol Neurosurg Psychiatry (1960) 90.89
An inventory for measuring depression. Arch Gen Psychiatry (1961) 84.61
A new depression scale designed to be sensitive to change. Br J Psychiatry (1979) 36.40
A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry (1978) 25.54
Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci (1986) 18.17
Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996. Electroencephalogr Clin Neurophysiol (1998) 6.30
Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog Brain Res (1990) 5.79
Frontal-subcortical circuits and human behavior. Arch Neurol (1993) 5.61
Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med (1998) 4.72
Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet (1996) 3.33
Posteroventral medial pallidotomy in advanced Parkinson's disease. N Engl J Med (1997) 3.23
Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial. Am J Psychiatry (1997) 3.02
A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med (2000) 2.92
Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and meta-analysis. Br J Psychiatry (2003) 2.61
Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: a double-blind controlled study. Arch Gen Psychiatry (1999) 2.55
Bi-frontal stereotactic tractotomy. A follow-up study of its effects on 210 patients. Br J Psychiatry (1971) 2.45
A controlled trial of daily left prefrontal cortex TMS for treating depression. Biol Psychiatry (2000) 2.39
Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology (1998) 2.32
Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry (2005) 2.24
Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease. J Neurol Neurosurg Psychiatry (2004) 2.21
A further review of the results of sterotactic subcaudate tractotomy. Br J Psychiatry (1975) 2.13
Deep brain stimulation of the ventral caudate nucleus in the treatment of obsessive-compulsive disorder and major depression. Case report. J Neurosurg (2004) 2.09
Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport (1995) 2.06
Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsia (2000) 2.02
A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. The Vagus Nerve Stimulation Study Group. Neurology (1995) 1.94
Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatry (2005) 1.90
Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry (2004) 1.86
Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. Arch Gen Psychiatry (2003) 1.81
Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: preliminary results of a randomized trial. Biol Psychiatry (2002) 1.81
Slow transcranial magnetic stimulation can rapidly reduce resistant auditory hallucinations in schizophrenia. Biol Psychiatry (2005) 1.78
Therapeutic mechanisms of vagus nerve stimulation. Neurology (2002) 1.75
Double-blind controlled investigation of bilateral prefrontal transcranial magnetic stimulation for the treatment of resistant major depression. Psychol Med (2003) 1.73
Transcranial magnetic stimulation in mania: a controlled study. Am J Psychiatry (1998) 1.71
Effects of coil design on delivery of focal magnetic stimulation. Technical considerations. Electroencephalogr Clin Neurophysiol (1990) 1.69
Deep brain stimulation for treatment-refractory obsessive-compulsive disorder: psychopathological and neuropsychological outcome in three cases. Acta Psychiatr Scand (2003) 1.68
Impaired motor cortex inhibition in patients with amyotrophic lateral sclerosis. Evidence from paired transcranial magnetic stimulation. Neurology (1997) 1.67
Transcranial magnetic stimulation for auditory hallucinations in schizophrenia. Psychiatry Res (2004) 1.66
STEREOTACTIC TRACTOTOMY IN THE SURGICAL TREATMENT OF MENTAL ILLNESS. J Neurol Neurosurg Psychiatry (1965) 1.65
Transcranial magnetic stimulation: studying the brain-behaviour relationship by induction of 'virtual lesions'. Philos Trans R Soc Lond B Biol Sci (1999) 1.64
A controlled study of repetitive transcranial magnetic stimulation as a treatment of depression in the elderly. Int Psychogeriatr (2001) 1.63
Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol Psychiatry (2000) 1.61
An investigation of motor function in schizophrenia using transcranial magnetic stimulation of the motor cortex. Br J Psychiatry (1996) 1.54
Simultaneous repetitive transcranial magnetic stimulation does not speed fine movement in PD. Neurology (1999) 1.54
Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. First International Vagus Nerve Stimulation Study Group. Epilepsia (1994) 1.54
Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation. Epilepsia (1998) 1.52
Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. Int J Neuropsychopharmacol (2002) 1.51
A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatry (2005) 1.48
A 3-month, follow-up, randomized, placebo-controlled study of repetitive transcranial magnetic stimulation in depression. J Clin Psychiatry (2004) 1.48
Reduced cortical excitability in depression. Impaired post-exercise motor facilitation with transcranial magnetic stimulation. Br J Psychiatry (1999) 1.45
Cingulotomy for refractory obsessive-compulsive disorder. A long-term follow-up of 33 patients. Arch Gen Psychiatry (1991) 1.44
Deep brain stimulation. Cell Tissue Res (2004) 1.42
The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism. J Neurophysiol (1994) 1.38
A new lesion for the psychosurgical operation of stereotactic subcaudate tractotomy (SST) Br J Neurosurg (1998) 1.38
A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression. Biol Psychiatry (2000) 1.37
Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial. Arch Gen Psychiatry (2003) 1.36
Vagus nerve stimulation. Epilepsia (1998) 1.34
Treatment of psychiatric illness by stereotactic cingulotomy. Biol Psychiatry (1987) 1.31
Acute blood flow changes and efficacy of vagus nerve stimulation in partial epilepsy. Neurology (1999) 1.29
A randomized controlled comparison of electroconvulsive therapy and repetitive transcranial magnetic stimulation in severe and resistant nonpsychotic major depression. Biol Psychiatry (2003) 1.26
Double-blind controlled investigation of transcranial magnetic stimulation for the treatment of resistant major depression. Am J Psychiatry (1999) 1.23
A.E. Bennett Research Award. Anatomic basis for differential regulation of the rostrolateral peri-locus coeruleus region by limbic afferents. Biol Psychiatry (1999) 1.21
Add-on rTMS for medication-resistant depression: a randomized, double-blind, sham-controlled trial in Chinese patients. J Clin Psychiatry (2005) 1.19
Can left prefrontal rTMS be used as a maintenance treatment for bipolar depression? Depress Anxiety (2004) 1.18
Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study. Biol Psychiatry (2005) 1.17
Transcranial magnetic stimulation and auditory hallucinations in schizophrenia. Lancet (2000) 1.16
Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: an open study. Biol Psychiatry (2000) 1.16
Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy. Bipolar Disord (2003) 1.15
Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Res (2000) 1.13
Repetitive transcranial magnetic stimulation (rTMS) in pharmacotherapy-refractory major depression: comparative study of fast, slow and sham rTMS. Psychiatry Res (1999) 1.13
Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a preliminary study. Am J Psychiatry (1997) 1.11
Psychosurgery: past, present, and future. Brain Res Brain Res Rev (2005) 1.10
Right prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a double-blind, placebo-controlled study. Am J Psychiatry (2001) 1.08
Deep brain stimulation for psychiatric disorders. J Clin Neurophysiol (2004) 1.07
The effects of transcranial magnetic stimulation over the dorsolateral prefrontal cortex on suppression of habitual counting during random number generation. Brain (1998) 1.05
Facilitation of picture naming by focal transcranial magnetic stimulation of Wernicke's area. Exp Brain Res (1998) 1.04
Antidepressant efficacy of two different rTMS procedures. High frequency over left versus low frequency over right prefrontal cortex compared with sham stimulation. Eur Arch Psychiatry Clin Neurosci (2003) 1.04
A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders. Crit Rev Neurobiol (1999) 1.03
Altered cortical excitability in obsessive-compulsive disorder. Neurology (2000) 1.03
Effect of transcranial magnetic stimulation in posttraumatic stress disorder: a preliminary study. Biol Psychiatry (1998) 1.02
Repetitive transcranial magnetic stimulation has a beneficial effect on bradykinesia in Parkinson's disease. Neuroreport (1999) 1.01
Repetitive transcranial magnetic stimulation (rTMS) in major depression: relation between efficacy and stimulation intensity. Neuropsychopharmacology (2002) 1.01
Left prefrontal activation predicts therapeutic effects of repetitive transcranial magnetic stimulation (rTMS) in major depression. Psychiatry Res (2000) 1.01
High-frequency repetitive transcranial magnetic stimulation delays rapid eye movement sleep. Neuroreport (1998) 1.00
High frequency repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex in schizophrenic patients. Neuroreport (2000) 0.99
Comparison of unlimited numbers of rapid transcranial magnetic stimulation (rTMS) and ECT treatment sessions in major depressive episode. Int J Neuropsychopharmacol (2000) 0.99
Slow-frequency repetitive transcranial magnetic stimulation in a patient with focal cortical dysplasia. Epilepsia (2000) 0.98
Anatomy and function of the orbital frontal cortex, II: Function and relevance to obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci (1996) 0.98
Motor cortical excitability in schizophrenia. Biol Psychiatry (2002) 0.98
Repetitive transcranial magnetic stimulation: a putative add-on treatment for major depression in elderly patients. Psychiatry Res (2004) 0.98
Efficacy of vagal nerve stimulation in children with medically refractory epilepsy. Neurosurgery (2000) 0.98
Right versus left prefrontal transcranial magnetic stimulation for obsessive-compulsive disorder: a preliminary investigation. J Clin Psychiatry (2001) 0.97
Repetitive transcranial magnetic stimulation as treatment of poststroke depression: a preliminary study. Biol Psychiatry (2004) 0.97
Magnetic resonance imaging-guided stereotactic limbic leukotomy for treatment of intractable psychiatric disease. Neurosurgery (2002) 0.97
A transcranial magnetic stimulation study of inhibitory deficits in the motor cortex in patients with schizophrenia. Psychiatry Res (2002) 0.97
Animal models of the mechanisms of action of repetitive transcranial magnetic stimulation (RTMS): comparisons with electroconvulsive shock (ECS). Depress Anxiety (2000) 0.96
Transcranial magnetic stimulation induces alterations in brain monoamines. J Neural Transm (Vienna) (1997) 0.95
Induction of errors in a delayed response task by repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex. Neuroreport (1994) 0.95
An institutional experience with cervical vagus nerve trunk stimulation for medically refractory epilepsy: rationale, technique, and outcome. Neurosurgery (1998) 0.95
Transcranial magnetic stimulation: studying motor neurophysiology of psychiatric disorders. Psychopharmacology (Berl) (2003) 0.95
Modest adjunctive benefit with transcranial magnetic stimulation in medication-resistant depression. J Affect Disord (2001) 0.94
Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry (2007) 5.59
Brain reserve and dementia: a systematic review. Psychol Med (2005) 3.24
Complications of Meckel's diverticula in adults. Can J Surg (2006) 3.16
Transcranial direct current stimulation for depression: 3-week, randomised, sham-controlled trial. Br J Psychiatry (2012) 2.83
Morphine hyperalgesia gated through microglia-mediated disruption of neuronal Cl⁻ homeostasis. Nat Neurosci (2013) 2.37
Pathways to alcohol-induced brain impairment in young people: a review. Cortex (2012) 2.25
The topography of white matter hyperintensities on brain MRI in healthy 60- to 64-year-old individuals. Neuroimage (2004) 2.04
A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder. Biol Psychiatry (2008) 2.03
Determinants of disparities between perceived and physiological risk of falling among elderly people: cohort study. BMJ (2010) 2.02
An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript. J Biol Chem (2002) 2.00
Management of acute paraesophageal hernia. Surg Endosc (2008) 1.95
ECT in the 21st century: optimizing treatment: state of the art in the 21st century. J ECT (2010) 1.95
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90
Increased abundance of opioid receptor heteromers after chronic morphine administration. Sci Signal (2010) 1.90
Reduced hippocampal volumes and memory loss in patients with early- and late-onset depression. Br J Psychiatry (2005) 1.90
Can cognitive exercise prevent the onset of dementia? Systematic review of randomized clinical trials with longitudinal follow-up. Am J Geriatr Psychiatry (2009) 1.89
Brain reserve and cognitive decline: a non-parametric systematic review. Psychol Med (2006) 1.82
Neuropathic pain: a practical guide for the clinician. CMAJ (2006) 1.79
A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder. Psychoneuroendocrinology (2009) 1.71
Atypical depression: a reappraisal. Am J Psychiatry (2002) 1.71
TNF-alpha and neuropathic pain--a review. J Neuroinflammation (2010) 1.68
Diffuse axonal injury in severe traumatic brain injury visualized using high-resolution diffusion tensor imaging. J Neurotrauma (2007) 1.67
Discrete neuroanatomical networks are associated with specific cognitive abilities in old age. J Neurosci (2011) 1.61
Lifespan mental activity predicts diminished rate of hippocampal atrophy. PLoS One (2008) 1.59
Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia. Bipolar Disord (2007) 1.59
Sex and symmetry differences in hippocampal volumetrics: before and beyond the opening of the crus of the fornix. Hippocampus (2006) 1.59
Treatment-resistant depression: critique of current approaches. Aust N Z J Psychiatry (2008) 1.54
Transcranial motor-evoked potentials combined with response recording through compound muscle action potential as the sole modality of spinal cord monitoring in spinal deformity surgery. Spine (Phila Pa 1976) (2008) 1.52
Abnormalities of the fornix in mild cognitive impairment are related to episodic memory loss. J Alzheimers Dis (2012) 1.52
Prevalence and correlates of DSM-IV major depression in an Australian national survey. J Affect Disord (2003) 1.47
A Systematic Review and Meta-Analysis of Brief Versus Ultrabrief Right Unilateral Electroconvulsive Therapy for Depression. J Clin Psychiatry (2015) 1.46
A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear. J Psychiatr Res (2006) 1.44
A randomized controlled trial of the effect of D-cycloserine on extinction and fear conditioning in humans. Behav Res Ther (2006) 1.44
Transient loss of motor-evoked responses associated with caudal injection of morphine in a patient with spondylolisthesis undergoing spinal fusion. Paediatr Anaesth (2006) 1.39
The cognitive and neurophysiological basis of emotion dysregulation in bipolar disorder. J Affect Disord (2007) 1.38
Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia. J Neurol Sci (2004) 1.38
Reduced activation to implicit affect induction in euthymic bipolar patients: an fMRI study. J Affect Disord (2006) 1.31
An emotional Stroop functional MRI study of euthymic bipolar disorder. Bipolar Disord (2005) 1.30
White matter integrity in mild cognitive impairment: a tract-based spatial statistics study. Neuroimage (2010) 1.30
Regulation of delta-opioid receptor trafficking via mu-opioid receptor stimulation: evidence from mu-opioid receptor knock-out mice. J Neurosci (2003) 1.26
Plasma biomarkers for mild cognitive impairment and Alzheimer's disease. Brain Res Rev (2009) 1.25
White matter hyperintensities and within-person variability in community-dwelling adults aged 60-64 years. Neuropsychologia (2007) 1.24
Memory training alters hippocampal neurochemistry in healthy elderly. Neuroreport (2003) 1.24
Functional MRI BOLD response to Tower of London performance of first-episode schizophrenia patients using cortical pattern matching. Neuroimage (2005) 1.23
Cognitive generation of affect in bipolar depression: an fMRI study. Eur J Neurosci (2004) 1.21
Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory protein-1. J Biol Chem (2010) 1.20
Optimal weights for local multi-atlas fusion using supervised learning and dynamic information (SuperDyn): validation on hippocampus segmentation. Neuroimage (2011) 1.18
Complex mental activity and the aging brain: molecular, cellular and cortical network mechanisms. Brain Res Rev (2007) 1.17
Cognitive lifestyle and long-term risk of dementia and survival after diagnosis in a multicenter population-based cohort. Am J Epidemiol (2011) 1.15
When more is less: associations between corpus callosum size and handedness lateralization. Neuroimage (2010) 1.14
Assessment of complex mental activity across the lifespan: development of the Lifetime of Experiences Questionnaire (LEQ). Psychol Med (2006) 1.14
Changing topological patterns in normal aging using large-scale structural networks. Neurobiol Aging (2010) 1.13
Neuropsychological performance in patients with depression is associated with clinical, etiological and genetic risk factors. J Clin Exp Neuropsychol (2003) 1.13
Risk factors of transition from normal cognition to mild cognitive disorder: the PATH through Life Study. Dement Geriatr Cogn Disord (2009) 1.12
A double-blind, sham-controlled trial of transcranial direct current stimulation for the treatment of depression. Int J Neuropsychopharmacol (2009) 1.12
Systemic inflammation is associated with MCI and its subtypes: the Sydney Memory and Aging Study. Dement Geriatr Cogn Disord (2011) 1.12
Familial idiopathic basal ganglia calcification (Fahr's disease) without neurological, cognitive and psychiatric symptoms is not linked to the IBGC1 locus on chromosome 14q. Hum Genet (2001) 1.11
Is a lack of disgust something to fear? A functional magnetic resonance imaging facial emotion recognition study in euthymic bipolar disorder patients. Bipolar Disord (2007) 1.11
Diagnostic guidelines for bipolar disorder: a summary of the International Society for Bipolar Disorders Diagnostic Guidelines Task Force Report. Bipolar Disord (2008) 1.11
Caudate nucleus volumes and genetic determinants of homocysteine metabolism in the prediction of psychomotor speed in older persons with depression. Am J Psychiatry (2002) 1.11
Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain. Eur J Pain (2006) 1.10
Within-occasion intraindividual variability and preclinical diagnostic status: is intraindividual variability an indicator of mild cognitive impairment? Neuropsychology (2005) 1.10
Higher normal fasting plasma glucose is associated with hippocampal atrophy: The PATH Study. Neurology (2012) 1.10
The association between systemic inflammation and cognitive performance in the elderly: the Sydney Memory and Ageing Study. Age (Dordr) (2011) 1.09
Do people become more apathetic as they grow older? A longitudinal study in healthy individuals. Int Psychogeriatr (2009) 1.09
The brain reserve hypothesis, brain atrophy and aging. Gerontology (2006) 1.09
Ultra-low dose naltrexone attenuates chronic morphine-induced gliosis in rats. Mol Pain (2010) 1.08
Corpus callosum size, reaction time speed and variability in mild cognitive disorders and in a normative sample. Neuropsychologia (2007) 1.07
Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimul (2010) 1.07
Uncovering the potential risk of serotonin toxicity in Australian veterans using pharmaceutical claims data. Br J Clin Pharmacol (2008) 1.05
Cognitive generation of affect in hypomania: an fMRI study. Bipolar Disord (2004) 1.05
Verrucous carcinoma of the esophagus eluding multiple sets of endoscopic biopsies and endoscopic ultrasound: a case report and review of the literature. Can J Gastroenterol (2004) 1.04
Stress-induced grey matter loss determined by MRI is primarily due to loss of dendrites and their synapses. Mol Neurobiol (2012) 1.02
A high-risk study of bipolar disorder. Childhood clinical phenotypes as precursors of major mood disorders. Arch Gen Psychiatry (2011) 1.02
Morphine-induced changes in delta opioid receptor trafficking are linked to somatosensory processing in the rat spinal cord. J Neurosci (2004) 1.02
Mu-opioid receptor knockout prevents changes in delta-opioid receptor trafficking induced by chronic inflammatory pain. Pain (2004) 1.01
Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial. J Clin Psychiatry (2008) 1.01
Mentalizing impairment in schizophrenia: a functional MRI study. Schizophr Res (2011) 1.01
Brief screening tests during acute admission in patients with mild stroke are predictive of vascular cognitive impairment 3-6 months after stroke. J Neurol Neurosurg Psychiatry (2012) 1.01
Distinguishing early and late onset non-melancholic unipolar depression. J Affect Disord (2003) 1.01
Functional brain maps of Tower of London performance: a positron emission tomography and functional magnetic resonance imaging study. Neuroimage (2003) 0.99
Outcome of laparoscopic splenectomy with preoperative splenic artery embolization for massive splenomegaly. Surg Endosc (2010) 0.99
Volumetrics of the caudate nucleus: reliability and validity of a new manual tracing protocol. Psychiatry Res (2008) 0.99
Recent rodent models for Alzheimer's disease: clinical implications and basic research. J Neural Transm (Vienna) (2011) 0.99
Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease. Biochem Soc Trans (2008) 0.99
Memory and executive functioning in obsessive-compulsive disorder: a selective review. J Affect Disord (2007) 0.99
The effect of simulation in improving students' performance in laparoscopic surgery: a meta-analysis. Surg Endosc (2012) 0.98
Transcranial direct current stimulation (tDCS): does it have merit in stroke rehabilitation? A systematic review. Int J Stroke (2013) 0.98
Behavioral and psychological symptoms associated with dementia subtype and severity. Int Psychogeriatr (2009) 0.97
Weekly alcohol consumption, brain atrophy, and white matter hyperintensities in a community-based sample aged 60 to 64 years. Psychosom Med (2006) 0.97
Macrophage inhibitory cytokine-1 is associated with cognitive impairment and predicts cognitive decline - the Sydney Memory and Aging Study. Aging Cell (2013) 0.96
Internet-delivered cognitive behavioural therapy for depression: a feasibility open trial for older adults. Aust N Z J Psychiatry (2012) 0.96
White matter hyperintensities are an independent predictor of physical decline in community-dwelling older people. Gerontology (2012) 0.95
The association between financial hardship and amygdala and hippocampal volumes: results from the PATH through life project. Soc Cogn Affect Neurosci (2011) 0.95
Anatomical abnormalities of the anterior cingulate and paracingulate cortex in patients with bipolar I disorder. Psychiatry Res (2008) 0.94